Chukwuka Eze

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 19

Top Topics

Brain Metastases

Prognostic Factors

Radiation Therapy

Top Venues

Radiation oncology (London, England)

The clinical respiratory journal

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Farkhad Manapov, Alexander Nieto, Lukas Käsmann, Julian Taugner, Saskia Kenndoff, Benedikt Flörsch, Julian Guggenberger, Kerstin Hofstetter, Sophie Kröninger, Janina Lehmann, Helene Kravutske, Carolyn Pelikan, Claus Belka, Chukwuka Eze
Five years after PACIFIC: Update on multimodal treatment efficacy based on real-world reports. Expert opinion on investigational drugs (2023)
Moritz Rabe, Miguel A Palacios, John R van Sörnsen de Koste, Chukwuka Eze, Martin Hillbrand, Claus Belka, Guillaume Landry, Suresh Senan, Christopher Kurz
Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy. Medical physics (2023)
Chukwuka Eze, Elia Lombardo, Lukas Nierer, Yuqing Xiong, Maximilian Niyazi, Claus Belka, Farkhad Manapov, Stefanie Corradini
MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients. Radiation oncology (London, England) 17 (1) (2022)
Chukwuka Eze, Isabelle Friedrich, Indrawati Hadi, Nina-Sophie Schmidt-Hegemann, Sarah Nindya Hartoyo, Richard Trauth, Daniel Reitz, Farkhad Manapov, Axel Siefert, Martin Dreyling, Claus Belka, Minglun Li
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis. European journal of haematology 109 (1) (2022)
Chukwuka Eze, Julian Elias Guggenberger, Nina-Sophie Schmidt-Hegemann, Saskia Kenndoff, Julian Taugner, Lukas Käsmann, Stephan Schönecker, Benedikt Flörsch, Minglun Li, Claus Belka, Farkhad Manapov
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve. Cancer 128 (12) (2022)
Lukas Käsmann, Julian Taugner, Alexander Nieto, Claus Belka, Chukwuka Eze, Farkhad Manapov
Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic. Journal of clinical medicine 11 (19) (2022)
Indrawati Hadi, Chukwuka Eze, Stephan Schönecker, Rieke von Bestenbostel, Paul Rogowski, Lukas Nierer, Raphael Bodensohn, Michael Reiner, Guillaume Landry, Claus Belka, Maximilian Niyazi, Stefanie Corradini
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience. Radiation oncology (London, England) 17 (1) (2022)
Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino Morris Sawicki, Julian Kirchner, Olarn Roengvoraphoj, Lukas Käsmann, Lena M Mittlmeier, Wolfgang G Kunz, Amanda Tufman, Julien Dinkel, Jens Ricke, Claus Belka, Farkhad Manapov, Marcus Unterrainer
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions. European journal of nuclear medicine and molecular imaging 48 (12) (2021)
Montserrat Pazos, Chukwuka Eze, Kathrin Kahnert, Maria Delius, Amanda Tufman, Irene Alba-Alejandre, Marcus Unterrainer, Jens Neumann, Thomas Kirchner, Farkhad Manapov
Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)-A Case Report. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Chukwuka Eze, Julian Taugner, Nina Sophie Schmidt-Hegemann, Lukas Käsmann, Julian Elias Guggenberger, Olarn Roengvoraphoj, Maurice Dantes, Arteda Gjika, Minglun Li, Claus Belka, Farkhad Manapov
Feasibility of hypofractionated radiotherapy in inoperable node-positive NSCLC patients with poor prognostic factors and limited pulmonary reserve: a prospective observational study. Acta oncologica (Stockholm, Sweden) 60 (8) (2021)
Julian Taugner, Lukas Käsmann, Chukwuka Eze, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting. Cancers 13 (7) (2021)
Diego Kauffmann-Guerrero, Julian Taugner, Chukwuka Eze, Lukas Käsmann, Minglun Li, Amanda Tufman, Farkhad Manapov
Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer-A Prospective Longitudinal Assessment. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Farkhad Manapov, Chukwuka Eze, Julian Taugner, Benedikt Flörsch, Lukas Käsmann
Combination of pembrolizumab with radiotherapy can change treatment paradigm in metastatic "non-driver" non-small-cell lung cancer: Assembling a path. The clinical respiratory journal 15 (10) (2021)
Nina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, Christian Schaefer, Christian Stief, Sebastian Lang, Simon Spohn, Rieke Steffens, Minglun Li, Christian Gratzke, Wolfgang Schultze-Seemann, Harun Ilhan, Wolfgang Peter Fendler, Peter Bartenstein, Ute Ganswindt, Alexander Buchner, Anca-Ligia Grosu, Claus Belka, Philipp Tobias Meyer, Simon Kirste, Constantinos Zamboglou
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis. Cancers 12 (11) (2020)
Maurice Dantes, Lukas Käsmann, Olarn Roengvoraphoj, Farkhad Manapov, Chukwuka Eze
Adjuvant radiotherapy additionally to chemotherapy in resected node-positive small cell lung cancer: A role assessment without randomized evidence. The clinical respiratory journal 14 (5) (2020)
Farkhad Manapov, Lukas Käsmann, Olarn Roengvoraphoj, Claus Belka, Chukwuka Eze
Multimodal "synergistic" treatment based on tumour immunological contexture for advanced non-driver non-small cell lung cancer: A myth or reality? European journal of cancer care 29 (5) (2020)
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Maurice Dantes, Nina-Sophie Schmidt-Hegemann, Sanziana Schiopu, Claus Belka, Farkhad Manapov
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. Radiation oncology (London, England) 15 (1) (2020)
Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Lukas Käsmann, Cherylina Wijaya, Claus Belka, Farkhad Manapov
Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis. Radiation oncology (London, England) 14 (1) (2019)
Chukwuka Eze, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Lukas Käsmann, Maurice Dantes, Farkhad Manapov
Chemoradiotherapy of stage III small-cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence? The clinical respiratory journal 12 (10) (2019)